Bicket Mark C, Long Jane J, Pronovost Peter J, Alexander G Caleb, Wu Christopher L
Johns Hopkins University School of Medicine, Baltimore, Maryland.
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
JAMA Surg. 2017 Nov 1;152(11):1066-1071. doi: 10.1001/jamasurg.2017.0831.
Prescription opioid analgesics play an important role in the treatment of postoperative pain; however, unused opioids may be diverted for nonmedical use and contribute to opioid-related injuries and deaths.
To quantify how commonly postoperative prescription opioids are unused, why they remain unused, and what practices are followed regarding their storage and disposal.
MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched from database inception to October 18, 2016, for studies describing opioid oversupply for adults after a surgical procedure. The primary outcome-opioid oversupply-was defined as the number of patients with either filled but unused opioid prescriptions or unfilled opioid prescriptions. Two reviewers independently screened studies for inclusion, extracted data, and assessed the study quality.
Six eligible studies reported on a total of 810 unique patients (range, 30-250 patients) who underwent 7 different types of surgical procedures. Across the 6 studies, 67% to 92% of patients reported unused opioids. Of all the opioid tablets obtained by surgical patients, 42% to 71% went unused. Most patients stopped or used no opioids owing to adequate pain control, and 16% to 29% of patients reported opioid-induced adverse effects. In 2 studies examining storage safety, 73% to 77% of patients reported that their prescription opioids were not stored in locked containers. All studies reported low rates of anticipated or actual disposal, but no study reported US Food and Drug Administration-recommended disposal methods in more than 9% of patients.
Postoperative prescription opioids often go unused, unlocked, and undisposed, suggesting an important reservoir of opioids contributing to nonmedical use of these products, which could cause injuries or even deaths.
处方阿片类镇痛药在术后疼痛治疗中发挥着重要作用;然而,未使用的阿片类药物可能会被用于非医疗用途,从而导致与阿片类药物相关的伤害和死亡。
量化术后处方阿片类药物未使用的常见程度、未使用的原因以及关于其储存和处置所遵循的做法。
检索了MEDLINE、EMBASE和Cochrane对照试验中心注册库,从数据库建立至2016年10月18日,查找描述成人手术后阿片类药物供应过剩的研究。主要结局——阿片类药物供应过剩——定义为有已配药但未使用的阿片类药物处方或未配药的阿片类药物处方的患者数量。两名评审员独立筛选纳入研究、提取数据并评估研究质量。
六项符合条件的研究共报告了810名接受7种不同类型手术的独特患者(范围为30 - 250名患者)。在这六项研究中,67%至92%的患者报告有未使用的阿片类药物。在手术患者获得的所有阿片类片剂中,42%至71%未被使用。大多数患者因疼痛得到充分控制而停用或未使用阿片类药物,16%至29%的患者报告有阿片类药物引起的不良反应。在两项检查储存安全性的研究中,73%至77%的患者报告其处方阿片类药物未储存在上锁的容器中。所有研究均报告预期或实际处置率较低,但没有研究报告超过9%的患者采用美国食品药品监督管理局推荐的处置方法。
术后处方阿片类药物常常未被使用、未上锁且未处置,这表明这些药物是导致这些产品被用于非医疗用途的一个重要来源,而这可能会造成伤害甚至死亡。